Interpharm Holdings, Inc.
IPAH - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$667
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $667.00 |
|---|---|
| Enterprise Value | $38.43 Million |
| Earnings per Share | $-0.26 |
| Beta | -1.65 |
| Outstanding Shares | 66,738,000 |
Return
| Return on Equity | 554.62% |
|---|---|
| Return on Assets | -45.63% |
| Return on Invested Capital | -97.00% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 0.56 |
| Enterprise Value to EBIT | -1.95 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 1 |
| Debt to Equity | -7.27 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Interpharm Holdings, Inc.
670 employees
CEO: Raj Sutaria
Interpharm Holdings, Inc. specializes in the formulation, manufacturing, and commercialization of generic pharmaceuticals, encompassing both prescription-strength and over-the-counter varieties. The company's medicinal products are suppl...